EA202090115A1 - НОВАЯ СОЛЬ N-(2,6-ДИЭТИЛФЕНИЛ)-8-({4-[4-(ДИМЕТИЛАМИНО)ПИПЕРИДИН-1-ИЛ]-2-МЕТОКСИФЕНИЛ}АМИНО)-1-МЕТИЛ-4,5-ДИГИДРО-1H-ПИРАЗОЛО[4,3-h]ХИНАЗОЛИН-3-КАРБОКСАМИДА, ЕЕ ПОЛУЧЕНИЕ И ПРЕПАРАТЫ, КОТОРЫЕ ЕЕ СОДЕРЖАТ - Google Patents
НОВАЯ СОЛЬ N-(2,6-ДИЭТИЛФЕНИЛ)-8-({4-[4-(ДИМЕТИЛАМИНО)ПИПЕРИДИН-1-ИЛ]-2-МЕТОКСИФЕНИЛ}АМИНО)-1-МЕТИЛ-4,5-ДИГИДРО-1H-ПИРАЗОЛО[4,3-h]ХИНАЗОЛИН-3-КАРБОКСАМИДА, ЕЕ ПОЛУЧЕНИЕ И ПРЕПАРАТЫ, КОТОРЫЕ ЕЕ СОДЕРЖАТInfo
- Publication number
- EA202090115A1 EA202090115A1 EA202090115A EA202090115A EA202090115A1 EA 202090115 A1 EA202090115 A1 EA 202090115A1 EA 202090115 A EA202090115 A EA 202090115A EA 202090115 A EA202090115 A EA 202090115A EA 202090115 A1 EA202090115 A1 EA 202090115A1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- diethylphenyl
- quinazoline
- piperidin
- methoxyphenyl
- dihydro
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/42—Phosphorus; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Inorganic Chemistry (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Virology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Hydrogenated Pyridines (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
Предложен новый N-(2,6-диэтилфенил)-8-({4-[4-(диметиламино)пиперидин-1-ил]-2-метоксифенил}амино)-1-метил-4,5-дигидро-1H-пиразоло[4,3-b]хиназолин-3-карбоксамид фосфат формулы (II)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP17305826 | 2017-06-29 | ||
PCT/EP2018/067394 WO2019002454A1 (en) | 2017-06-29 | 2018-06-28 | NOVEL N- (2,6-DIETHYLPHENYL) -8 - ({4- [4- (DIMETHYLAMINO) PIPERIDIN-1-YL] -2-METHOXYPHENYL} AMINO) -1-METHYL-4,5-DIHYDRO-1H SALT -PYRAZOLO [4,3-H] QUINAZOLINE-3-CARBOXAMIDE, ITS PREPARATION AND FORMULATIONS CONTAINING THE SAME |
Publications (2)
Publication Number | Publication Date |
---|---|
EA202090115A1 true EA202090115A1 (ru) | 2020-05-25 |
EA039764B1 EA039764B1 (ru) | 2022-03-11 |
Family
ID=59313166
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EA202090115A EA039764B1 (ru) | 2017-06-29 | 2018-06-28 | Соль n-(2,6-диэтилфенил)-8-({4-[4-(диметиламино)пиперидин-1-ил]-2-метоксифенил}амино)-1-метил-4,5-дигидро-1h-пиразоло[4,3-h]хиназолин-3-карбоксамида, ее получение и препараты, которые ее содержат |
Country Status (19)
Country | Link |
---|---|
US (2) | US11160806B2 (ru) |
EP (1) | EP3645535B1 (ru) |
JP (1) | JP7141416B2 (ru) |
KR (1) | KR102609333B1 (ru) |
CN (1) | CN110896636B (ru) |
AR (1) | AR112040A1 (ru) |
AU (1) | AU2018293729B9 (ru) |
BR (1) | BR112019027924A2 (ru) |
CA (1) | CA3068357C (ru) |
CL (1) | CL2019003848A1 (ru) |
EA (1) | EA039764B1 (ru) |
ES (1) | ES2900048T3 (ru) |
IL (1) | IL271628B2 (ru) |
MA (1) | MA49498A (ru) |
PL (1) | PL3645535T3 (ru) |
SG (1) | SG11201912651WA (ru) |
TW (1) | TWI750393B (ru) |
UY (1) | UY37778A (ru) |
WO (1) | WO2019002454A1 (ru) |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DK2303891T3 (en) | 2008-06-26 | 2016-05-30 | Servier Lab | PYRAZOLO-quinazolines as modulators of protein kinase-ACTIVITY |
-
2018
- 2018-06-21 UY UY0001037778A patent/UY37778A/es unknown
- 2018-06-28 SG SG11201912651WA patent/SG11201912651WA/en unknown
- 2018-06-28 JP JP2019572116A patent/JP7141416B2/ja active Active
- 2018-06-28 KR KR1020207002339A patent/KR102609333B1/ko active IP Right Grant
- 2018-06-28 PL PL18732820T patent/PL3645535T3/pl unknown
- 2018-06-28 US US16/624,488 patent/US11160806B2/en active Active
- 2018-06-28 WO PCT/EP2018/067394 patent/WO2019002454A1/en unknown
- 2018-06-28 EP EP18732820.8A patent/EP3645535B1/en active Active
- 2018-06-28 CN CN201880043442.0A patent/CN110896636B/zh active Active
- 2018-06-28 ES ES18732820T patent/ES2900048T3/es active Active
- 2018-06-28 EA EA202090115A patent/EA039764B1/ru unknown
- 2018-06-28 AR ARP180101781A patent/AR112040A1/es unknown
- 2018-06-28 AU AU2018293729A patent/AU2018293729B9/en active Active
- 2018-06-28 TW TW107122235A patent/TWI750393B/zh active
- 2018-06-28 MA MA049498A patent/MA49498A/fr unknown
- 2018-06-28 BR BR112019027924-5A patent/BR112019027924A2/pt unknown
- 2018-06-28 CA CA3068357A patent/CA3068357C/en active Active
-
2019
- 2019-12-22 IL IL271628A patent/IL271628B2/en unknown
- 2019-12-26 CL CL2019003848A patent/CL2019003848A1/es unknown
-
2021
- 2021-09-30 US US17/490,318 patent/US20220016122A1/en active Pending
Also Published As
Publication number | Publication date |
---|---|
US11160806B2 (en) | 2021-11-02 |
CL2019003848A1 (es) | 2020-07-10 |
KR20200020905A (ko) | 2020-02-26 |
CN110896636B (zh) | 2022-07-19 |
EA039764B1 (ru) | 2022-03-11 |
IL271628B1 (en) | 2023-03-01 |
BR112019027924A2 (pt) | 2020-08-18 |
IL271628A (en) | 2020-02-27 |
AR112040A1 (es) | 2019-09-11 |
UY37778A (es) | 2019-01-31 |
TWI750393B (zh) | 2021-12-21 |
CN110896636A (zh) | 2020-03-20 |
KR102609333B1 (ko) | 2023-12-01 |
ES2900048T3 (es) | 2022-03-15 |
US20220016122A1 (en) | 2022-01-20 |
AU2018293729A1 (en) | 2020-01-23 |
JP2020525477A (ja) | 2020-08-27 |
AU2018293729B2 (en) | 2022-03-10 |
AU2018293729B9 (en) | 2022-07-14 |
EP3645535B1 (en) | 2021-09-08 |
CA3068357A1 (en) | 2019-01-03 |
MA49498A (fr) | 2021-05-26 |
EP3645535A1 (en) | 2020-05-06 |
SG11201912651WA (en) | 2020-01-30 |
PL3645535T3 (pl) | 2022-03-21 |
WO2019002454A1 (en) | 2019-01-03 |
US20200246339A1 (en) | 2020-08-06 |
IL271628B2 (en) | 2023-07-01 |
CA3068357C (en) | 2022-04-19 |
TW201904971A (zh) | 2019-02-01 |
JP7141416B2 (ja) | 2022-09-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CY1125007T1 (el) | Ενωσεις και χημικες συνθεσεις ως αναστολεις ενδοσωμικων υποδοχεων τυπου toll | |
EA201791692A1 (ru) | 4H-ПИРРОЛО[3,2-c]ПИРИДИН-4-ОНОВЫЕ ПРОИЗВОДНЫЕ | |
PE20171307A1 (es) | Compuestos de triazolopirimidina y usos de los mismos | |
MX2018003215A (es) | Derivados de imidazo[4,5-c]quinolina e imidazo[4,5-c][1,5]naftirid ina novedosos como inhibidores de lrrk2. | |
EA201291098A1 (ru) | Новые соединения 3,5-дизамещенного-3h-имидазо[4,5-b]пиридина и 3,5-дизамещенного -3h-[1,2,3]триазоло[4,5-b]пиридина как модуляторы протеинкиназ | |
EA201300620A1 (ru) | ПРОИЗВОДНЫЕ ИМИДАЗО[1,2-b]ПИРИДАЗИНА И ИМИДАЗО[4,5-b]ПИРИДИНА В КАЧЕСТВЕ ИНГИБИТОРОВ JAK | |
EA202090258A3 (ru) | Производные пирроло[3,2-d]пиримидина для лечения вирусных инфекций и других заболеваний | |
EA201790658A1 (ru) | Производные диарилмочевины в качестве ингибиторов киназы p38 | |
EA201590391A1 (ru) | Пиразолилмочевины в качестве ингибиторов киназы | |
PH12020550143A1 (en) | Salts of pyrrolotriazine derivatives useful as tam inhibitors | |
EA201591904A1 (ru) | НОВЫЕ ПРОИЗВОДНЫЕ N-(2,3-ДИГИДРО-1H-ПИРРОЛО[2,3-b]ПИРИДИН-5-ИЛ)-4-ХИНАЗОЛИНАМИНА И N-(2,3-ДИГИДРО-1H-ИНДОЛ-5-ИЛ)-4-ХИНАЗОЛИНАМИНА В КАЧЕСТВЕ ИНГИБИТОРОВ PERK | |
BR112021023607A2 (pt) | Derivados de pirrolo[2,3-b]piridina e pirazolo[3,4-b]piridina substituídos por inibidores de proteína quinase | |
EA201792057A1 (ru) | Конденсированные бициклические гетероарильные производные с активностью ингибиторов пролилгидроксилазы | |
ECSP22012347A (es) | Derivados de 2-morfolinopiridina sustituidos como inhibidores de la cinasa atr | |
EA201991355A1 (ru) | Производные имидазо[1,5-а]пиразина в качестве ингибиторов pi3kдельта | |
EA202191478A1 (ru) | Гетероароматические соединения в качестве ингибиторов ванина | |
BR112017001517A2 (pt) | bases livres cristalinas de inibidor de c-met, ou sais cristalinos do inibidor com ácidos, e métodos de preparo e uso destes | |
EA201790179A1 (ru) | [1,2,4]триазоло[4,3-b]пиридазины для применения в лечении пролиферативных заболеваний | |
EA201300997A1 (ru) | ПИРИДО[2,3-b]ПИРАЗИНОВЫЕ ПРОИЗВОДНЫЕ И ИХ ТЕРАПЕВТИЧЕСКИЕ ПРИМЕНЕНИЯ | |
MX2018010177A (es) | Compuestos de 6,7-dihidro-5h-pirazolo[5,1-b][1,3]oxazina-2-carboxa mida. | |
EA201890922A1 (ru) | Циклические простоэфирные производные пиразоло[1,5-а]пиримидин-3-карбоксамида | |
PH12020550485A1 (en) | Crystalline salts of a b-raf kinase inhibitor | |
EA202090115A1 (ru) | НОВАЯ СОЛЬ N-(2,6-ДИЭТИЛФЕНИЛ)-8-({4-[4-(ДИМЕТИЛАМИНО)ПИПЕРИДИН-1-ИЛ]-2-МЕТОКСИФЕНИЛ}АМИНО)-1-МЕТИЛ-4,5-ДИГИДРО-1H-ПИРАЗОЛО[4,3-h]ХИНАЗОЛИН-3-КАРБОКСАМИДА, ЕЕ ПОЛУЧЕНИЕ И ПРЕПАРАТЫ, КОТОРЫЕ ЕЕ СОДЕРЖАТ | |
EA201991095A1 (ru) | Замещенные азотсодержащие соединения | |
EA202191477A1 (ru) | Гетероароматические соединения в качестве ингибиторов ванина |